Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma

被引：1
|
作者：
Quinn, Kristen M. [1 ]
Tozbikian, Gary [1 ]
Carson, William E. [1 ]
机构：
[1] Ohio State Univ, James Canc Hosp, Div Surg Oncol, Columbus, OH 43210 USA
来源：
CLINICAL CASE REPORTS | 2018年 / 6卷 / 12期
关键词：
breast cancer; eccrine adenocarcinoma; phyllodes tumor; radiotherapy;
D O I：
10.1002/ccr3.1854
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Clinical Message This unusual case of concurrent eccrine adenocarcinoma, phyllodes tumor, and multinodular goiter serves to alert the oncologic community to the high prevalence of second cancers after childhood radiotherapy. Increased surveillance and index of suspicion are recommended to successfully diagnose and treat second primary cancers in this vulnerable population.
引用
收藏
页码：2498 / 2503
页数：6
相关论文
共 23 条
  • [21] Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma
    Bertolini, F
    Fusetti, L
    Mancuso, P
    Gobbi, A
    Corsini, C
    Ferrucci, PF
    Martinelli, G
    Pruneri, G
    BLOOD, 2000, 96 (01) : 282 - 287
  • [22] Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database
    Yang, Zejian
    Li, Kunlong
    Qiu, Pei
    Ma, Yifei
    Wang, Bin
    Yan, Yu
    Meng, Du
    Feng, Chen
    Ren, Yu
    Li, Yijun
    Li, Pingping
    Zhou, Can
    BREAST, 2021, 60 : 287 - 294
  • [23] Randomized intergroup trial of first line treatment for patients <=60 years with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab -: early stopping after the first interim analysis.
    Pfreundschuh, MG
    Trümper, L
    Ma, D
    Österborg, A
    Pettengell, R
    Trneny, M
    Shepherd, L
    Waleswski, J
    Zinzani, PL
    Loeffler, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 558S - 558S
123